Loading...
Oncometabolite L‐2‐hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma
Metabolism reprograming is a hallmark of cancer and plays an important role in tumor progression. The aberrant metabolism in renal cell carcinoma (RCC) leads to accumulation of the oncometabolite l‐2‐hydroxyglurate (L‐2HG). L‐2HG has been reported to inhibit the activity of some α‐ketoglutarate‐depe...
Saved in:
| Published in: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley & Sons, Inc.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7986127/ https://ncbi.nlm.nih.gov/pubmed/33320958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|